Study Programmes 2015-2016
Faculty of Medicine
Specialised master in industrial pharmacy
Cycle view
Block view
print
Block view of the study programmeOrThPrOtCr
Bloc 1 du programme de l'année
Compulsory courses
 PHIN2004-1Q16
 Active substances
  -10-- 
 Substances issues de recherches pharmacochimiques, part a - Bernard Pirotte
  -5-- 
 Substances issues de recherches pharmacochimiques, part b - Françoise Dufrasne
  -15-- 
 Substances issues des biotechnologies - David Vermijlen
  -5-- 
 Substances d'origine naturelle, part a - Joëlle Quetin-Leclercq
  -5-- 
 Substances d'origine naturelle, part b - Pierre Duez
  -10-- 
 Produits radiopharmaceutiques - Ghanem Ghanem
 PHIN2008-26
 Clinical viewpoints
  -20-- 
 Métabolisme des médicaments et paramètres pharmacocinétiques - Roger Verbeek
  -15-- 
 Aspects théoriques et pratiques des études cliniques (y compris les méthodes statistiques appliquées aux études cliniques) - Régis Radermecker
  -10-- 
 Information et pharmacovigilance - Raphaël Denooz
 PHIN2013-27
 Quality assurance and pharmaceutical management
  -10-- 
 Principles of pharmaceutical management - Jean-Michel Van Der Hofstadt
  -20-- 
 Quality assurance, part a : basic concepts and quality assurance organisation - Jean Scouvart
  -7,5-- 
 Quality assurance, part b : Analytical technology of procedures and risk analysis - Xavier Marcelis
  -20-- 
 English applied to the pharmaceutical industry - Jacques Poupaert, Nevin Serbest
  -7,5-- 
 Pharmaceutical marketing - Vincent Bierlaire
 PHIN2033-18
 Industrial pharmaceutical technology
  -15-- 
 Industrial pharmaceutical microbiology - Véronique Fontaine
  -15-- 
 Preformulation and selection of galenical forms - Karim Amighi
  -15-- 
 Industrial production of galenical forms - Brigitte Evrard
  -15-- 
 Industrial production of biomolecules - Philippe Leveque, Rita Van Bever
  -10-- 
 Industrial aspects of technological development including packaging - Laurence Denis
 PHIN2023-17
 Drug analysis
  -10-- 
 Analytical methods and pharmaceutical and biopharmaceutical control, part a - Jean-Michel Kauffman, Pierre Van Antwerpen
  -10-- 
 Analytical methods and pharmaceutical and biopharmaceutical control, part b - Marianne Fillet
  -15-- 
 Methods in pharmaceutical and biopharmaceutical analysis, part a : Validation and qualification of equipment - Philippe Hubert, Roland Marini Djang'Eing'A
  -5-- 
 Methods in pharmaceutical and biopharmaceutical analysis, part b : Process analytical technology - Philippe Hubert, Eric Ziemons
  -15-- 
 Statistical methods applied to the pharmaceutical industry - Bernadette Govaerts
  -10-- 
 Experimental planning and "quality by design" - Bruno Boulanger
 PHIN2029-28
 Regulation and the medical-social environment
  -10-- 
 Economic aspects of drug development - Dominique Martin
  -105- 
 Legislation and procedures applied to pharmaceutical industry, part a : legislation - Catherine Druez
  -5-- 
 Legislation and procedures applied to pharmaceutical industry, part b : patents and protection - Patrick Di Stefano
  -10-- 
 Macroeconomic environment and pharmaco-economics - Pierre Duez
  -15-- 
 CTD File (Common Technical Document) - Jean-Antoine De Muylder
  -15-- 
 Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files - Sonia Beken
  -5-- 
 Regulations of preclinical and clinical studies, part b : clinical studies - A Lenaers
  -2,5-- 
 Regulations of preclinical and clinical studies, part c : pediatric studies - Daniel Brasseur
  -5-- 
 Specific regulatory issues, part a : medicine and herbal dietary supplement - Michel Frederich
  -5-- 
 Specific regulatory issues, part b : Preformulation and galenical development documentation - Francis Vanderbist
 PHIN2032-1--[+]3
 Visits and seminars organised in the pharmaceutical industry - Françoise Dufrasne, Brigitte Evrard, Rita Van Bever - [77,5h Vis.]
 MTFE2000-1---15
 Final work - Françoise Dufrasne, Brigitte Evrard, Rita Van Bever